dihexa hgf/c-met agonist Frontiers

Dihexa is a synthetic peptide derived from Angiotensin IV, engineered to cross the blood-brain barrier and activate the HGF/c-Met pathway — a primary driver of synaptogenesis and new neural connection growth. Researchers

26.45

★★★★☆4.8 (126)

A novel agonist for the HGF receptor MET promotes differentiation of human pluripotent stem cells into hepatocyte‐like cells - Tauran - 2022 - Development, Growth & Differentiation

29.67

★★★★★4.9 (98)

Exploring the science behind Dihexa., Preclinical research examines its interaction with the HGF/c-Met pathway and associated neuroplasticity markers in laboratory and animal models. Human data

22.85

★★★★★5.0 (157)

dihexa hgf/c-met agonist Molecular mechanism(s) of regulation(s) of c-MET/ HGF signaling in head and neck cancer

26.94

★★★★★4.7 (84)

Growth factors and their peptide mimetics for treatment of traumatic brain injury

27.33

★★★★★4.9 (203)

Dihexa (also known as PNB-0408) is an experimental small molecule derived from angiotensin IV. It was engineered to cross the blood–brain barrier and has shown synaptogenic effects in preclinical models. The often-quoted

24.22

★★★★★5.0 (176)

Artificial human Met agonists based on macrocycle scaffolds

21.58

★★★★★4.8 (132)